The approval of Covaxin, which is still undergoing phase-3 clinical trials and yet to have efficacy data, has been roundly criticised. But Krishna Ella, Chairman and Managing Director of Bharat Biotech, the maker of Covaxin, feels a lot of that criticism is not justified. Here’s a look at what he had to say about its efficacy and immunogenicity data, administering it in ‘clinical trial mode’ and whether it is just a ‘back-up’ vaccine
The company saw a seven percent decline in net loss from Rs 1,904 crore in FY19 to Rs 1,771 crore in FY20, according to Tofler.
20 charts that define 2020: From banned apps to most-downloaded apps and the most-searched terms to the people most tweeted about, check out the events that charted the course of the Indian economy this past year.
The year 2020 reminded us that conserving money in important. COVID-19 brought out the importance of a health insurance cover. And investments remained volatile.
As banks turned to focus on pure transactional banking business amidst COVID-19, insurance agents have become a useful resource.
COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate.
Sachin Bansal and Ankit Agarwal co-founded financials services company Navi Technologies in 2018, after the former's exit from Flipkart.
Seven stocks in which MFs raised stake in the past four quarters doubled investors wealth in 2020.
As per the MoU, SpiceJet will deploy a dedicated fleet of freighters, including wide-body aircraft, at Hyderabad airport to handle all domestic and international consignments.